Шифр: BS3/2009/115/3 Журнал 2009р. Vol. 115 N 3 Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. - P.425-432 Інші автори: , , McCafferty M., McNeill R., Miller N., Kerin M. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis. - P.433-439 Інші автори: , , Mauri D., Valachis A., Polyzos I., Polyzos N., Kamposioras K., Pesce L. Glucocorticoid receptor expression in breast cancer associates with older patient age. - P.441-447 Інші автори: , , Belova L., Delgado B., Kocherginsky M., Melhem A., Olopade O., Conzen S. Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas. - P.449-460 Інші автори: , , Wargon V., Helguero L., Bolado J., Rojas P., Novaro V., Molinolo A., Lanari C. Characterization of the weak estrogen receptor agonistic activity of exemestane. - P.461-470 Інші автори: , , Masri S., Lui K., Phung S., Ye J., Zhou D., Wang X., Chen S. Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis. - P.471-478 Інші автори: , , Chen L., Zhu Z., Sun X., Dong X.-Y., Wei J., Gu F., Sun Y., Zhou J., Dong J., Fu L. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. - P.479-489 Інші автори: , , Joosse S., Beers E., Tielen I., Horlings H., Peterse J., Hoogerbrugge N., Ligtenberg M., Wessels L., Axwijk P., Verhoef S., Hogervorst F., Nederlof P. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93. - P.491-500 Інші автори: , , Pagani O., Gelber S., Simoncini E., Astiglione-Gertsch M., Price K., Gelber R., Holmberg S., Crivellari D., Collins J., Lindtner J., Thurlimann B., Fey M., Murray E., Forbes J., Coates A., Goldhirsch A. Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. - P.501-508 Інші автори: , , Falandry C., Debled M., Bachelot T., Delozier T., Cretin J., Romestaing P., Mille D., You B., Mauriac L., Pujade-Lauraine E., Freyer G. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial. - P.509-520 Інші автори: , , Jezequel P., Campone M., Roche H., Gouraud W., Charbonnel C., Ricolleau G., Magrangeas F., Minvielle S., Geneve J., Martin A., Bataille R., Campion L. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. - P.521-527 Інші автори: , , Osborne C., Duncan A., Sedlacek S., Paul D., Holmes F., Vukelja S., Kasper M., Wilks S., Schneider A., McGee R., Meyer W., O’Shaughnessy J. Barton, D. Does hormonal therapy decrease tamoxifen associated hot flashes? / D. Barton, C. Loprinzi. - P.529-530 A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer. - P.531-538 Інші автори: , , Cheville A., Das I., Srinivas S., Schuerman J., Velders L., Solin L., Basu S., Alavi A. Buchholz, T. Identifying the “sentinel lymph nodes” for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy / T. Buchholz, R. Avritscher, T. Yu. - P.539-541 Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. - P.543-549 Інші автори: , , Schneider B., Radovich M., Flockhart D., Carpenter J., Li L., Robarge J., Storniolo A., Hancock B., Skaar T., Sledge G. Alcohol and folate intake and breast cancer risk in the WHI Observational Study. - P.551-562 Інші автори: , , Duffy C., Assaf A., Cyr M., Burkholder G., Coccio E., Rohan T., McTiernan A., Paskett E., Lane D., Chetty V.K. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. - P.563-570 Інші автори: , , Rao N., Hu Z., Yu J., Li W., Zhang B., Su F., Wu J., Shen Z., Huang W., Shao Z. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. - P.571-575 Інші автори: , , Lu C., Dong J., Ma H., Jin G., Hu Z., Peng Y., Guo X., Wang X., Shen H. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. - P.577-586 Інші автори: , , Ottini L., Rizzolo P., Zanna I., Falchetti M., Masala G., Ceccarelli K., Vezzosi V., Gulino A., Giannini G., Bianchi S., Sera F., Palli D. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. - P.587-594 Інші автори: , , Atkinson C., Newton K., Bowles E., Lehman C., Stanczyk F., Westerlind K., Li L., Lampe J. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. - P.595-602 Інші автори: , , Dignam J., Dukic V., Anderson S., Mamounas E., Wickerham D., Wolmark N. Brown, S. Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme / S. Brown, D. Morrison, T. Cooke. - P.603-607 Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. - P.609-616 Інші автори: , , Ahn E., Cho J., Shin D., Park B., Ahn S., Noh D., Nam S., Lee E., Yun Y. Machado, P. Caution should be taken in the methodology used to confirm c.156-157insAlu BRCA2 mutation / P. Machado, F. Vaz. - P.617-618 Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer. - P.619-620 Інші автори: , , Eroglu A., Cam R., Egin Y., Akar N. Teugels, E. About the c.156-157insAlu BRCA2 breast cancer predisposing mutation / E. Teugels, J. Greve. - P.621-622 Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1) |
Шифр: BS3/2009/116/3 Журнал 2009р. Vol. 116 N 3 Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. - P.425-432 Інші автори: , , McCafferty M., McNeill R., Miller N., Kerin M. Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis. - P.433-439 Інші автори: , , Mauri D., Valachis A., Polyzos I., Polyzos N., Kamposioras K., Pesce L. Glucocorticoid receptor expression in breast cancer associates with older patient age. - P.441-447 Інші автори: , , Belova L., Delgado B., Kocherginsky M., Melhem A., Olopade O., Conzen S. Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas. - P.449-460 Інші автори: , , Wargon V., Helguero L., Bolado J., Rojas P., Novaro V., Molinolo A., Lanari C. Characterization of the weak estrogen receptor alpha agonistic activity of exemestane. - P.461-470 Інші автори: , , Masri S., Lui K., Phung S., Ye J., Zhou D., Wang X., Chen S. Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis. - P.471-478 Інші автори: , , Chen L., Zhu Z., Sun X., Dong X., Wei J., Gu F., Sun Y., Zhou J., Dong J., Fu L. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. - P.479-489 Інші автори: , , Joosse S., Beers E., Tielen I., Horlings H., Peterse J., Hoogerbrugge N., Ligtenberg M., Wessels L., Axwijk P., Verhoef S., Hogervorst F., Nederlof P. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93. - P.491-500 Інші автори: , , Pagani O., Gelber S., Simoncini E., Castiglione-Gertsch M., Price K., Gelber R., Holmberg S., Crivellari D., Collins J., Lindtner J., Thurlimann B., Fey M., Murray E., Forbes J., Coates A., Goldhirsch A. Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. - P.501-508 Інші автори: , , Falandry C., Debled M., Bachelot T., Delozier T., Cretin J., Romestaing P., Mille D., You B., Mauriac L., Pujade-Lauraine E., Freyer G. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial. - P.509-520 Інші автори: , , Jezequel P., Campone M., Roche H., Gouraud W., Charbonnel C., Ricolleau G., Magrangeas F., Minvielle S., Geneve J., Martin A., Bataille R., Campion L. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. - P.521-527 Інші автори: , , Osborne C., Duncan A., Sedlacek S., Paul D., Holmes F., Vukelja S., Kasper M., Wilks S., Schneider A., McGee R., Meyer W., O’Shaughnessy J. Barton, D. Does hormonal therapy decrease tamoxifen associated hot flashes? / D. Barton, C. Loprinzi. - P.529-530 A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer. - P.531-538 Інші автори: , , Cheville A., Das I., Srinivas S., Schuerman J., Velders L., Solin L., Basu S., Alavi A. Buchholz, T. Identifying the “sentinel lymph nodes” for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy / T. Buchholz, R. Avritscher, T. Yu. - P.539-541 Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. - P.543-549 Інші автори: , , Schneider B., Radovich M., Flockhart D., Carpenter J., Lang L., Jason D., Anna M., Bradley A., Todd C., George W. Alcohol and folate intake and breast cancer risk in the WHI Observational Study. - P.551-562 Інші автори: , , Duffy C., Assaf A., Cyr M., Burkholder G., Coccio E., Rohan T., McTiernan A., Paskett E., Lane D., Chetty V.K. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. - P.563-570 Інші автори: , , Rao N., Hu Z., Yu J., Li W., Zhang B., Su F., Wu J., Shen Z., Huang W., Shao Z. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. - P.571-575 Інші автори: , , Lu C., Dong J., Ma H., Jin G., Hu Z., Peng Y., Guo X., Wang X., Shen H. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. - P.577-586 Інші автори: , , Ottini L., Rizzolo P., Zanna I., Falchetti M., Masala G., Ceccarelli K., Vezzosi V., Gulino A., Giannini G., Bianchi S., Sera F., Palli D. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. - P.587-594 Інші автори: , , Atkinson C., Newton K., Bowles E., Lehman C., Stanczyk F., Westerlind K., Li L., Lampe J. Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. - P.595-602 Інші автори: , , Dignam J., Dukic V., Anderson S., Mamounas E., Wickerham D., Wolmark N. Brown, S. Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme / S. Brown, D. Morrison, T. Cooke. - P.603-607 Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. - P.609-616 Інші автори: , , Ahn E., Cho J., Shin D., Park B., Ahn S., Noh D., Nam S., Lee E., Yun Y. Machado, P. Caution should be taken in the methodology used to confirm c.156_157insAlu BRCA2 mutation / P. Machado, F. Vaz. - P.617-618 Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer. - P.619-620 Інші автори: , , Eroglu A., Cam R., Egin Y., Akar N. Teugels, E. About the c.156_157insAlu BRCA2 breast cancer predisposing mutation / E. Teugels, J. Greve. - P.621-622 Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1) |
Barton, D. Does hormonal therapy decrease tamoxifen associated hot flashes? [Electronic resource] / D. Barton, C. Loprinzi // Breast Cancer Research and Treatment. - 2009. - Vol. 115, N 3. - P529-530 . - ISSN 1573-7217 Есть полнотекстовые версии (для доступа требуется авторизация) Дод.точки доступу: Loprinzi, C. Примірників всього: 1 ВКТ (1) Свободны: ВКТ (1) |
Barton, D. Does hormonal therapy decrease tamoxifen associated hot flashes? [Electronic resource] / D. Barton, C. Loprinzi // Breast Cancer Research and Treatment. - 2009. - Vol. 116, N 3. - P529-530 . - ISSN 1573-7217 Есть полнотекстовые версии (для доступа требуется авторизация) Дод.точки доступу: Loprinzi, C. Примірників всього: 1 ВКТ (1) Свободны: ВКТ (1) |